Figure 2From: Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands Estimated HAV seroprevalence by age group in 2000 and 2030 (upper panel); the estimated proportion of the population with HAV immunity between 2000 and 2030 for selected age groups (lower panel). Back to article page